Clinical Trial Update: Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pTVG-HP in combination with nivolumab and targeted ablation for resistant lesions in non-castrate recurrent oligometastatic prostate ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• nivolumab (nivolumab)
• pTVG-HP

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer Patients, Non-castrate Prostate Cancer | Phase 1 | Status: RECRUITING